Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Neurology ; (12): 245-250, 2023.
Artigo em Chinês | WPRIM | ID: wpr-994826

RESUMO

The rapid advancement of biomarker research in Alzheimer′s disease (AD) has improved the accuracy of AD diagnosis, facilitated its early diagnosis and intervention, and has significant implications for disease-modifying therapy research and evaluation. Since its introduction, the AT(N) system has grown in importance in both the clinical and research aspects of AD. However, the fluid biomarkers in the AT(N) system do not yet adequately reflect the complex pathophysiology of AD. Other fluid biomarkers associated with neuroinflammation, synaptic dysfunction, and vascular dysfunction should be a valuable addition to the AT(N). In recent years, the development and application of peripheral blood biomarkers have greatly enriched the fluid biomarker system for AD and are expected to greatly facilitate early screening and diagnosis of the disease. Here, a brief overview of current research on AT(N) and other pathogenesis-related fluid biomarkers is presented, and the article proposes that fluid biomarkers for AD should be studied from a variety of pathophysiological perspectives in order to improve their role in disease diagnosis. This article also discusses the role and limitations of fluid biomarkers in the diagnosis of AD, as well as the future development and application of fluid biomarkers in AD.

2.
Journal of Chinese Physician ; (12): 468-470, 2016.
Artigo em Chinês | WPRIM | ID: wpr-488470

RESUMO

Over the last two decades,we have seen many advances in the biological underpinnings of many kinds of cancers that have had a significant impact either directly or indirectly on the management and ultimately on the prognostic outcome of this disease.Next-generation sequencing studies have provided further evidence to support the notion4 that cancer is a disease characterized by Darwinian evolution.However,Ones often fail to obtain the information in different stages of the tumor before making treatment decision.This may be the major reason for treatment failures.Currently,circulating tumor cells (CTCs) is considered as aliquid biopsy.By detecting CTCs at different stages of tumor and obtaining the biological characteristics of CTCs,ones can get information about tumor evolution at different stages.It might provide effective basis for individual therapy to tumors,and promote the accuracy of tumor treatment.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA